Reported by: Ijeoma G | Edited by: Henry Owen | Stone Reporter News
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public recall of specific batches of two antibiotic suspensions produced by Sam-Ace Ltd, Nigeria. The affected products include:
-
Astamocil (Amoxicillin Suspension 125mg/5ml) – Batch 826024
-
Astamentin (Amoxicillin/Clavulanic Acid Suspension 228.5 mg) – Batches 0503024 and 0501724
The recall follows findings from a recent Risk-Based Post-Marketing Surveillance conducted at the Coordinated Wholesale Centre (CWC) in Kano, which revealed that the products failed laboratory tests due to low Active Pharmaceutical Ingredient (API) content. NAFDAC has directed the manufacturer to withdraw the affected batches from circulation immediately.
About the medicines:
-
Amoxicillin is a penicillin-class antibacterial used to treat infections in the ear, nose, throat, genitourinary tract, skin, and lower respiratory tract caused by susceptible bacteria.
-
Amoxicillin/Clavulanic Acid is a combination antibiotic that prevents certain bacteria from resisting amoxicillin. It is prescribed for sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and skin infections.
Healthcare professionals and consumers are urged to remain vigilant and report any suspected sale of substandard or falsified medicines. Reports can be made at the nearest NAFDAC office, via 0800-162-3322, or by email at sf.alert@nafdac.gov.ng.
📰 Stone Reporter News
🌍 stonereportersnews.com | ✉️ info@stonereportersnews.com
📘 Facebook: Stone Reports | 🐦 X (Twitter): @StoneReportNew | 📸 Instagram: @stonereportersnews
Add comment
Comments